FIELD: medicine.
SUBSTANCE: invention relates to medicine, medical diagnostics and concerns the use of substance (4S,7S,10S,13S)-4-((1H-imidazol-4-yl)methyl)-13-carbamoyl-10-(2-carboxyethyl)-7-methyl-2,5,8,11-tetraoxo-3,6,9,12-tetraazagexadecane-16-acid (SRFM) as a blood biomarker for diagnosing human neurodegenerative disorders and diseases by measuring concentration of SRFM in blood plasma of an individual. Level of concentration of SRFM in blood plasma in an individual with diagnosed disease is reliably lower in comparison with level of concentration of SRFM in blood plasma in a healthy individual. If the individual’s blood plasma SRFM concentration falls over time, a neurodegenerative disorder or a pathological process, including asymptomatic, is diagnosed.
EFFECT: effective diagnosis of neurodegenerative disorders and diseases, such as Alzheimer's disease, Parkinson's disease, mild cognitive decline syndrome, amyotrophic lateral sclerosis syndrome, craniocerebral injuries, including at early stages and asymptomatic.
6 cl, 2 dwg, 6 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC TEST SYSTEM FOR DETERMINING BIOMARKER SPECIFIC FOR NEURODEGENERATIVE DISEASES OR NEURODEGENERATIVE DISORDERS | 2024 |
|
RU2827060C1 |
| SYNTHETIC TETRAPEPTIDE HAEE AND DERIVATIVES THEREOF INTENDED FOR PROTECTION OF HUMAN NEURON FUNCTION | 2023 |
|
RU2822602C1 |
| HAEE SYNTHETIC TETRAPEPTIDE AND DERIVATIVES THEREOF INTENDED FOR HUMAN NEURON FUNCTION RECOVERY | 2023 |
|
RU2822603C1 |
| METHOD FOR IDENTIFYING A GROUP OF PEOPLE WITH AN INCREASED RISK OF DEVELOPING ALZHEIMER'S DISEASE | 2021 |
|
RU2781612C1 |
| ANTIBODY, SET AND METHOD OF DETERMINATION OF AMILOIDNY PEPTIDES | 2012 |
|
RU2571213C2 |
| METHOD OF DIAGNOSTICS OF NEURODEGENERATIVE DISEASES | 2011 |
|
RU2567665C2 |
| LACTOFERRIN, USED IN DIAGNOSING OR PREDICTING ALZHEIMER'S DISEASE OR DIAGNOSING PARKINSON'S DISEASE | 2016 |
|
RU2745602C2 |
| METHODS AND REAGENTS FOR IMPROVEMENT OF DETECTING AMYLOID BETA-PEPTIDES | 2010 |
|
RU2554774C2 |
| METHOD FOR PREDICTING THE LIKELIHOOD OF DEVELOPING ALZHEIMER'S DISEASE (AD) | 2017 |
|
RU2663451C1 |
| BIOMARKER AND METHODS FOR EARLY DIAGNOSIS OF ALZHEIMER'S DISEASE | 2015 |
|
RU2687272C2 |
